nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—Tafluprost—PTGS2—thyroid cancer	0.01	1	CrCbGaD
Travoprost—Infestation—Vandetanib—thyroid cancer	0.00691	0.00698	CcSEcCtD
Travoprost—Infestation NOS—Vandetanib—thyroid cancer	0.00691	0.00698	CcSEcCtD
Travoprost—Depression—Vandetanib—thyroid cancer	0.00689	0.00696	CcSEcCtD
Travoprost—Urinary tract infection—Vandetanib—thyroid cancer	0.00672	0.00679	CcSEcCtD
Travoprost—Conjunctivitis—Vandetanib—thyroid cancer	0.00672	0.00679	CcSEcCtD
Travoprost—Prostatic disorder—Doxorubicin—thyroid cancer	0.0067	0.00677	CcSEcCtD
Travoprost—Sinusitis—Vandetanib—thyroid cancer	0.00648	0.00655	CcSEcCtD
Travoprost—Bradycardia—Vandetanib—thyroid cancer	0.00632	0.00638	CcSEcCtD
Travoprost—Urinary tract disorder—Vandetanib—thyroid cancer	0.00613	0.00619	CcSEcCtD
Travoprost—Urethral disorder—Vandetanib—thyroid cancer	0.00608	0.00614	CcSEcCtD
Travoprost—Visual impairment—Vandetanib—thyroid cancer	0.00598	0.00604	CcSEcCtD
Travoprost—Eye disorder—Vandetanib—thyroid cancer	0.0058	0.00586	CcSEcCtD
Travoprost—Cardiac disorder—Vandetanib—thyroid cancer	0.00576	0.00582	CcSEcCtD
Travoprost—Angiopathy—Vandetanib—thyroid cancer	0.00563	0.00569	CcSEcCtD
Travoprost—Mediastinal disorder—Vandetanib—thyroid cancer	0.00559	0.00565	CcSEcCtD
Travoprost—Mental disorder—Vandetanib—thyroid cancer	0.00544	0.00549	CcSEcCtD
Travoprost—Dysgeusia—Vandetanib—thyroid cancer	0.00529	0.00534	CcSEcCtD
Travoprost—Lacrimation—Epirubicin—thyroid cancer	0.00524	0.00529	CcSEcCtD
Travoprost—Skin hyperpigmentation—Epirubicin—thyroid cancer	0.00518	0.00523	CcSEcCtD
Travoprost—Vision blurred—Vandetanib—thyroid cancer	0.00509	0.00514	CcSEcCtD
Travoprost—Lacrimation—Doxorubicin—thyroid cancer	0.00485	0.0049	CcSEcCtD
Travoprost—Skin hyperpigmentation—Doxorubicin—thyroid cancer	0.00479	0.00484	CcSEcCtD
Travoprost—Keratitis—Epirubicin—thyroid cancer	0.00475	0.0048	CcSEcCtD
Travoprost—Cough—Vandetanib—thyroid cancer	0.00471	0.00476	CcSEcCtD
Travoprost—Hypertension—Vandetanib—thyroid cancer	0.00466	0.00471	CcSEcCtD
Travoprost—Infestation NOS—Sorafenib—thyroid cancer	0.00466	0.00471	CcSEcCtD
Travoprost—Infestation—Sorafenib—thyroid cancer	0.00466	0.00471	CcSEcCtD
Travoprost—Arthralgia—Vandetanib—thyroid cancer	0.0046	0.00464	CcSEcCtD
Travoprost—Chest pain—Vandetanib—thyroid cancer	0.0046	0.00464	CcSEcCtD
Travoprost—Anxiety—Vandetanib—thyroid cancer	0.00458	0.00463	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00457	0.00461	CcSEcCtD
Travoprost—Dry mouth—Vandetanib—thyroid cancer	0.0045	0.00454	CcSEcCtD
Travoprost—Oedema—Vandetanib—thyroid cancer	0.00441	0.00445	CcSEcCtD
Travoprost—Keratitis—Doxorubicin—thyroid cancer	0.00439	0.00444	CcSEcCtD
Travoprost—Infection—Vandetanib—thyroid cancer	0.00438	0.00442	CcSEcCtD
Travoprost—Nervous system disorder—Vandetanib—thyroid cancer	0.00432	0.00437	CcSEcCtD
Travoprost—Skin disorder—Vandetanib—thyroid cancer	0.00428	0.00432	CcSEcCtD
Travoprost—Dermatitis atopic—Epirubicin—thyroid cancer	0.00416	0.0042	CcSEcCtD
Travoprost—Urinary tract disorder—Sorafenib—thyroid cancer	0.00413	0.00417	CcSEcCtD
Travoprost—Connective tissue disorder—Sorafenib—thyroid cancer	0.00411	0.00415	CcSEcCtD
Travoprost—Urethral disorder—Sorafenib—thyroid cancer	0.0041	0.00414	CcSEcCtD
Travoprost—Scotoma—Epirubicin—thyroid cancer	0.00406	0.0041	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00402	0.00406	CcSEcCtD
Travoprost—Dyspnoea—Vandetanib—thyroid cancer	0.00393	0.00397	CcSEcCtD
Travoprost—Tinnitus—Sorafenib—thyroid cancer	0.0039	0.00394	CcSEcCtD
Travoprost—Cardiac disorder—Sorafenib—thyroid cancer	0.00388	0.00392	CcSEcCtD
Travoprost—Dyspepsia—Vandetanib—thyroid cancer	0.00388	0.00392	CcSEcCtD
Travoprost—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00385	0.00389	CcSEcCtD
Travoprost—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00381	0.00384	CcSEcCtD
Travoprost—Fatigue—Vandetanib—thyroid cancer	0.0038	0.00384	CcSEcCtD
Travoprost—Angiopathy—Sorafenib—thyroid cancer	0.0038	0.00384	CcSEcCtD
Travoprost—Immune system disorder—Sorafenib—thyroid cancer	0.00378	0.00382	CcSEcCtD
Travoprost—Mediastinal disorder—Sorafenib—thyroid cancer	0.00377	0.00381	CcSEcCtD
Travoprost—Pain—Vandetanib—thyroid cancer	0.00377	0.00381	CcSEcCtD
Travoprost—Constipation—Vandetanib—thyroid cancer	0.00377	0.00381	CcSEcCtD
Travoprost—Scotoma—Doxorubicin—thyroid cancer	0.00375	0.00379	CcSEcCtD
Travoprost—Dysphonia—Epirubicin—thyroid cancer	0.00374	0.00378	CcSEcCtD
Travoprost—Mental disorder—Sorafenib—thyroid cancer	0.00367	0.0037	CcSEcCtD
Travoprost—Erythema—Sorafenib—thyroid cancer	0.00364	0.00368	CcSEcCtD
Travoprost—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0036	0.00364	CcSEcCtD
Travoprost—Dysgeusia—Sorafenib—thyroid cancer	0.00357	0.0036	CcSEcCtD
Travoprost—Abdominal pain—Vandetanib—thyroid cancer	0.00348	0.00352	CcSEcCtD
Travoprost—Dysphonia—Doxorubicin—thyroid cancer	0.00346	0.0035	CcSEcCtD
Travoprost—Bone disorder—Epirubicin—thyroid cancer	0.00341	0.00344	CcSEcCtD
Travoprost—Skin discolouration—Epirubicin—thyroid cancer	0.00341	0.00344	CcSEcCtD
Travoprost—Lacrimation increased—Epirubicin—thyroid cancer	0.00334	0.00338	CcSEcCtD
Travoprost—Herpes simplex—Epirubicin—thyroid cancer	0.00334	0.00338	CcSEcCtD
Travoprost—Cough—Sorafenib—thyroid cancer	0.00318	0.00321	CcSEcCtD
Travoprost—Inflammation—Epirubicin—thyroid cancer	0.00318	0.00321	CcSEcCtD
Travoprost—Asthenia—Vandetanib—thyroid cancer	0.00316	0.00319	CcSEcCtD
Travoprost—Skin discolouration—Doxorubicin—thyroid cancer	0.00316	0.00319	CcSEcCtD
Travoprost—Bone disorder—Doxorubicin—thyroid cancer	0.00316	0.00319	CcSEcCtD
Travoprost—Hypertension—Sorafenib—thyroid cancer	0.00315	0.00318	CcSEcCtD
Travoprost—Pruritus—Vandetanib—thyroid cancer	0.00312	0.00315	CcSEcCtD
Travoprost—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00312	0.00315	CcSEcCtD
Travoprost—Myalgia—Sorafenib—thyroid cancer	0.0031	0.00313	CcSEcCtD
Travoprost—Arthralgia—Sorafenib—thyroid cancer	0.0031	0.00313	CcSEcCtD
Travoprost—Herpes simplex—Doxorubicin—thyroid cancer	0.00309	0.00312	CcSEcCtD
Travoprost—Lacrimation increased—Doxorubicin—thyroid cancer	0.00309	0.00312	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00308	0.00311	CcSEcCtD
Travoprost—Dermatitis contact—Epirubicin—thyroid cancer	0.00304	0.00307	CcSEcCtD
Travoprost—Dry mouth—Sorafenib—thyroid cancer	0.00303	0.00306	CcSEcCtD
Travoprost—Diarrhoea—Vandetanib—thyroid cancer	0.00302	0.00305	CcSEcCtD
Travoprost—Infection—Sorafenib—thyroid cancer	0.00295	0.00298	CcSEcCtD
Travoprost—Inflammation—Doxorubicin—thyroid cancer	0.00294	0.00297	CcSEcCtD
Travoprost—Nervous system disorder—Sorafenib—thyroid cancer	0.00292	0.00295	CcSEcCtD
Travoprost—Dizziness—Vandetanib—thyroid cancer	0.00291	0.00294	CcSEcCtD
Travoprost—Skin disorder—Sorafenib—thyroid cancer	0.00289	0.00292	CcSEcCtD
Travoprost—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00288	0.00291	CcSEcCtD
Travoprost—Dry eye—Epirubicin—thyroid cancer	0.00284	0.00287	CcSEcCtD
Travoprost—Dermatitis contact—Doxorubicin—thyroid cancer	0.00282	0.00284	CcSEcCtD
Travoprost—Rash—Vandetanib—thyroid cancer	0.00278	0.00281	CcSEcCtD
Travoprost—Dermatitis—Vandetanib—thyroid cancer	0.00278	0.0028	CcSEcCtD
Travoprost—Headache—Vandetanib—thyroid cancer	0.00276	0.00279	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00271	0.00274	CcSEcCtD
Travoprost—Abnormal vision—Epirubicin—thyroid cancer	0.00269	0.00271	CcSEcCtD
Travoprost—Dyspnoea—Sorafenib—thyroid cancer	0.00265	0.00268	CcSEcCtD
Travoprost—Dry eye—Doxorubicin—thyroid cancer	0.00263	0.00266	CcSEcCtD
Travoprost—Nausea—Vandetanib—thyroid cancer	0.00262	0.00264	CcSEcCtD
Travoprost—Dyspepsia—Sorafenib—thyroid cancer	0.00262	0.00264	CcSEcCtD
Travoprost—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00257	0.00259	CcSEcCtD
Travoprost—Fatigue—Sorafenib—thyroid cancer	0.00256	0.00259	CcSEcCtD
Travoprost—Pain—Sorafenib—thyroid cancer	0.00254	0.00257	CcSEcCtD
Travoprost—Constipation—Sorafenib—thyroid cancer	0.00254	0.00257	CcSEcCtD
Travoprost—Abnormal vision—Doxorubicin—thyroid cancer	0.00249	0.00251	CcSEcCtD
Travoprost—Eye pain—Epirubicin—thyroid cancer	0.00248	0.0025	CcSEcCtD
Travoprost—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00243	0.00246	CcSEcCtD
Travoprost—Abdominal pain—Sorafenib—thyroid cancer	0.00235	0.00237	CcSEcCtD
Travoprost—Eye pain—Doxorubicin—thyroid cancer	0.00229	0.00231	CcSEcCtD
Travoprost—Hypersensitivity—Sorafenib—thyroid cancer	0.00219	0.00221	CcSEcCtD
Travoprost—Asthenia—Sorafenib—thyroid cancer	0.00213	0.00215	CcSEcCtD
Travoprost—Pruritus—Sorafenib—thyroid cancer	0.0021	0.00212	CcSEcCtD
Travoprost—Diarrhoea—Sorafenib—thyroid cancer	0.00203	0.00205	CcSEcCtD
Travoprost—Dizziness—Sorafenib—thyroid cancer	0.00197	0.00199	CcSEcCtD
Travoprost—Influenza—Epirubicin—thyroid cancer	0.00193	0.00195	CcSEcCtD
Travoprost—Asthma—Epirubicin—thyroid cancer	0.00193	0.00195	CcSEcCtD
Travoprost—Angina pectoris—Epirubicin—thyroid cancer	0.00188	0.0019	CcSEcCtD
Travoprost—Rash—Sorafenib—thyroid cancer	0.00187	0.00189	CcSEcCtD
Travoprost—Dermatitis—Sorafenib—thyroid cancer	0.00187	0.00189	CcSEcCtD
Travoprost—Headache—Sorafenib—thyroid cancer	0.00186	0.00188	CcSEcCtD
Travoprost—Bronchitis—Epirubicin—thyroid cancer	0.00186	0.00188	CcSEcCtD
Travoprost—Dysuria—Epirubicin—thyroid cancer	0.00181	0.00183	CcSEcCtD
Travoprost—Influenza—Doxorubicin—thyroid cancer	0.00179	0.00181	CcSEcCtD
Travoprost—Asthma—Doxorubicin—thyroid cancer	0.00179	0.00181	CcSEcCtD
Travoprost—Nausea—Sorafenib—thyroid cancer	0.00177	0.00178	CcSEcCtD
Travoprost—Angina pectoris—Doxorubicin—thyroid cancer	0.00174	0.00176	CcSEcCtD
Travoprost—Infestation NOS—Epirubicin—thyroid cancer	0.00172	0.00174	CcSEcCtD
Travoprost—Infestation—Epirubicin—thyroid cancer	0.00172	0.00174	CcSEcCtD
Travoprost—Bronchitis—Doxorubicin—thyroid cancer	0.00172	0.00174	CcSEcCtD
Travoprost—Conjunctivitis—Epirubicin—thyroid cancer	0.00167	0.00169	CcSEcCtD
Travoprost—Urinary tract infection—Epirubicin—thyroid cancer	0.00167	0.00169	CcSEcCtD
Travoprost—Dysuria—Doxorubicin—thyroid cancer	0.00167	0.00169	CcSEcCtD
Travoprost—Sinusitis—Epirubicin—thyroid cancer	0.00162	0.00163	CcSEcCtD
Travoprost—Infestation NOS—Doxorubicin—thyroid cancer	0.00159	0.00161	CcSEcCtD
Travoprost—Infestation—Doxorubicin—thyroid cancer	0.00159	0.00161	CcSEcCtD
Travoprost—Bradycardia—Epirubicin—thyroid cancer	0.00157	0.00159	CcSEcCtD
Travoprost—Rhinitis—Epirubicin—thyroid cancer	0.00155	0.00157	CcSEcCtD
Travoprost—Urinary tract infection—Doxorubicin—thyroid cancer	0.00155	0.00157	CcSEcCtD
Travoprost—Conjunctivitis—Doxorubicin—thyroid cancer	0.00155	0.00157	CcSEcCtD
Travoprost—Pharyngitis—Epirubicin—thyroid cancer	0.00154	0.00155	CcSEcCtD
Travoprost—Urinary tract disorder—Epirubicin—thyroid cancer	0.00153	0.00154	CcSEcCtD
Travoprost—Connective tissue disorder—Epirubicin—thyroid cancer	0.00152	0.00154	CcSEcCtD
Travoprost—Urethral disorder—Epirubicin—thyroid cancer	0.00152	0.00153	CcSEcCtD
Travoprost—Sinusitis—Doxorubicin—thyroid cancer	0.0015	0.00151	CcSEcCtD
Travoprost—Visual impairment—Epirubicin—thyroid cancer	0.00149	0.00151	CcSEcCtD
Travoprost—Bradycardia—Doxorubicin—thyroid cancer	0.00146	0.00147	CcSEcCtD
Travoprost—Eye disorder—Epirubicin—thyroid cancer	0.00145	0.00146	CcSEcCtD
Travoprost—Tinnitus—Epirubicin—thyroid cancer	0.00144	0.00146	CcSEcCtD
Travoprost—Cardiac disorder—Epirubicin—thyroid cancer	0.00144	0.00145	CcSEcCtD
Travoprost—Rhinitis—Doxorubicin—thyroid cancer	0.00143	0.00145	CcSEcCtD
Travoprost—Pharyngitis—Doxorubicin—thyroid cancer	0.00142	0.00143	CcSEcCtD
Travoprost—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00141	0.00143	CcSEcCtD
Travoprost—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00141	0.00142	CcSEcCtD
Travoprost—Angiopathy—Epirubicin—thyroid cancer	0.0014	0.00142	CcSEcCtD
Travoprost—Urethral disorder—Doxorubicin—thyroid cancer	0.0014	0.00142	CcSEcCtD
Travoprost—Immune system disorder—Epirubicin—thyroid cancer	0.0014	0.00141	CcSEcCtD
Travoprost—Mediastinal disorder—Epirubicin—thyroid cancer	0.00139	0.00141	CcSEcCtD
Travoprost—Visual impairment—Doxorubicin—thyroid cancer	0.00138	0.00139	CcSEcCtD
Travoprost—Mental disorder—Epirubicin—thyroid cancer	0.00136	0.00137	CcSEcCtD
Travoprost—Erythema—Epirubicin—thyroid cancer	0.00135	0.00136	CcSEcCtD
Travoprost—Eye disorder—Doxorubicin—thyroid cancer	0.00134	0.00135	CcSEcCtD
Travoprost—Tinnitus—Doxorubicin—thyroid cancer	0.00133	0.00135	CcSEcCtD
Travoprost—Cardiac disorder—Doxorubicin—thyroid cancer	0.00133	0.00134	CcSEcCtD
Travoprost—Dysgeusia—Epirubicin—thyroid cancer	0.00132	0.00133	CcSEcCtD
Travoprost—Back pain—Epirubicin—thyroid cancer	0.0013	0.00132	CcSEcCtD
Travoprost—Angiopathy—Doxorubicin—thyroid cancer	0.0013	0.00131	CcSEcCtD
Travoprost—Immune system disorder—Doxorubicin—thyroid cancer	0.00129	0.00131	CcSEcCtD
Travoprost—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00129	0.0013	CcSEcCtD
Travoprost—Vision blurred—Epirubicin—thyroid cancer	0.00127	0.00128	CcSEcCtD
Travoprost—Mental disorder—Doxorubicin—thyroid cancer	0.00125	0.00127	CcSEcCtD
Travoprost—Ill-defined disorder—Epirubicin—thyroid cancer	0.00125	0.00126	CcSEcCtD
Travoprost—Erythema—Doxorubicin—thyroid cancer	0.00125	0.00126	CcSEcCtD
Travoprost—Dysgeusia—Doxorubicin—thyroid cancer	0.00122	0.00123	CcSEcCtD
Travoprost—Malaise—Epirubicin—thyroid cancer	0.00121	0.00123	CcSEcCtD
Travoprost—Vertigo—Epirubicin—thyroid cancer	0.00121	0.00122	CcSEcCtD
Travoprost—Back pain—Doxorubicin—thyroid cancer	0.00121	0.00122	CcSEcCtD
Travoprost—Palpitations—Epirubicin—thyroid cancer	0.00119	0.0012	CcSEcCtD
Travoprost—Cough—Epirubicin—thyroid cancer	0.00117	0.00119	CcSEcCtD
Travoprost—Vision blurred—Doxorubicin—thyroid cancer	0.00117	0.00119	CcSEcCtD
Travoprost—Hypertension—Epirubicin—thyroid cancer	0.00116	0.00117	CcSEcCtD
Travoprost—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00116	0.00117	CcSEcCtD
Travoprost—Myalgia—Epirubicin—thyroid cancer	0.00115	0.00116	CcSEcCtD
Travoprost—Arthralgia—Epirubicin—thyroid cancer	0.00115	0.00116	CcSEcCtD
Travoprost—Chest pain—Epirubicin—thyroid cancer	0.00115	0.00116	CcSEcCtD
Travoprost—Anxiety—Epirubicin—thyroid cancer	0.00114	0.00115	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00114	0.00115	CcSEcCtD
Travoprost—Discomfort—Epirubicin—thyroid cancer	0.00113	0.00114	CcSEcCtD
Travoprost—Malaise—Doxorubicin—thyroid cancer	0.00112	0.00113	CcSEcCtD
Travoprost—Dry mouth—Epirubicin—thyroid cancer	0.00112	0.00113	CcSEcCtD
Travoprost—Vertigo—Doxorubicin—thyroid cancer	0.00112	0.00113	CcSEcCtD
Travoprost—Palpitations—Doxorubicin—thyroid cancer	0.0011	0.00111	CcSEcCtD
Travoprost—Oedema—Epirubicin—thyroid cancer	0.0011	0.00111	CcSEcCtD
Travoprost—Infection—Epirubicin—thyroid cancer	0.00109	0.0011	CcSEcCtD
Travoprost—Cough—Doxorubicin—thyroid cancer	0.00109	0.0011	CcSEcCtD
Travoprost—Nervous system disorder—Epirubicin—thyroid cancer	0.00108	0.00109	CcSEcCtD
Travoprost—Hypertension—Doxorubicin—thyroid cancer	0.00108	0.00109	CcSEcCtD
Travoprost—Tachycardia—Epirubicin—thyroid cancer	0.00107	0.00108	CcSEcCtD
Travoprost—Skin disorder—Epirubicin—thyroid cancer	0.00107	0.00108	CcSEcCtD
Travoprost—Chest pain—Doxorubicin—thyroid cancer	0.00106	0.00107	CcSEcCtD
Travoprost—Myalgia—Doxorubicin—thyroid cancer	0.00106	0.00107	CcSEcCtD
Travoprost—Arthralgia—Doxorubicin—thyroid cancer	0.00106	0.00107	CcSEcCtD
Travoprost—Anxiety—Doxorubicin—thyroid cancer	0.00106	0.00107	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00105	0.00106	CcSEcCtD
Travoprost—Discomfort—Doxorubicin—thyroid cancer	0.00105	0.00106	CcSEcCtD
Travoprost—Dry mouth—Doxorubicin—thyroid cancer	0.00104	0.00105	CcSEcCtD
Travoprost—Hypotension—Epirubicin—thyroid cancer	0.00103	0.00104	CcSEcCtD
Travoprost—Oedema—Doxorubicin—thyroid cancer	0.00102	0.00103	CcSEcCtD
Travoprost—Infection—Doxorubicin—thyroid cancer	0.00101	0.00102	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.001	0.00101	CcSEcCtD
Travoprost—Nervous system disorder—Doxorubicin—thyroid cancer	0.000997	0.00101	CcSEcCtD
Travoprost—Tachycardia—Doxorubicin—thyroid cancer	0.000992	0.001	CcSEcCtD
Travoprost—Skin disorder—Doxorubicin—thyroid cancer	0.000988	0.000998	CcSEcCtD
Travoprost—Dyspnoea—Epirubicin—thyroid cancer	0.00098	0.00099	CcSEcCtD
Travoprost—Dyspepsia—Epirubicin—thyroid cancer	0.000967	0.000977	CcSEcCtD
Travoprost—Hypotension—Doxorubicin—thyroid cancer	0.00095	0.00096	CcSEcCtD
Travoprost—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000949	0.000958	CcSEcCtD
Travoprost—Fatigue—Epirubicin—thyroid cancer	0.000947	0.000957	CcSEcCtD
Travoprost—Pain—Epirubicin—thyroid cancer	0.00094	0.000949	CcSEcCtD
Travoprost—Constipation—Epirubicin—thyroid cancer	0.00094	0.000949	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000926	0.000936	CcSEcCtD
Travoprost—Dyspnoea—Doxorubicin—thyroid cancer	0.000906	0.000916	CcSEcCtD
Travoprost—Feeling abnormal—Epirubicin—thyroid cancer	0.000905	0.000915	CcSEcCtD
Travoprost—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000899	0.000908	CcSEcCtD
Travoprost—Dyspepsia—Doxorubicin—thyroid cancer	0.000895	0.000904	CcSEcCtD
Travoprost—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000878	0.000887	CcSEcCtD
Travoprost—Fatigue—Doxorubicin—thyroid cancer	0.000877	0.000885	CcSEcCtD
Travoprost—Pain—Doxorubicin—thyroid cancer	0.000869	0.000878	CcSEcCtD
Travoprost—Constipation—Doxorubicin—thyroid cancer	0.000869	0.000878	CcSEcCtD
Travoprost—Abdominal pain—Epirubicin—thyroid cancer	0.000869	0.000877	CcSEcCtD
Travoprost—Feeling abnormal—Doxorubicin—thyroid cancer	0.000838	0.000846	CcSEcCtD
Travoprost—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000831	0.00084	CcSEcCtD
Travoprost—Hypersensitivity—Epirubicin—thyroid cancer	0.00081	0.000818	CcSEcCtD
Travoprost—Abdominal pain—Doxorubicin—thyroid cancer	0.000804	0.000812	CcSEcCtD
Travoprost—Asthenia—Epirubicin—thyroid cancer	0.000788	0.000796	CcSEcCtD
Travoprost—Pruritus—Epirubicin—thyroid cancer	0.000777	0.000785	CcSEcCtD
Travoprost—Diarrhoea—Epirubicin—thyroid cancer	0.000752	0.000759	CcSEcCtD
Travoprost—Hypersensitivity—Doxorubicin—thyroid cancer	0.000749	0.000757	CcSEcCtD
Travoprost—Asthenia—Doxorubicin—thyroid cancer	0.000729	0.000737	CcSEcCtD
Travoprost—Dizziness—Epirubicin—thyroid cancer	0.000727	0.000734	CcSEcCtD
Travoprost—Pruritus—Doxorubicin—thyroid cancer	0.000719	0.000727	CcSEcCtD
Travoprost—Diarrhoea—Doxorubicin—thyroid cancer	0.000696	0.000703	CcSEcCtD
Travoprost—Rash—Epirubicin—thyroid cancer	0.000693	0.0007	CcSEcCtD
Travoprost—Dermatitis—Epirubicin—thyroid cancer	0.000692	0.000699	CcSEcCtD
Travoprost—Headache—Epirubicin—thyroid cancer	0.000688	0.000695	CcSEcCtD
Travoprost—Dizziness—Doxorubicin—thyroid cancer	0.000672	0.000679	CcSEcCtD
Travoprost—Nausea—Epirubicin—thyroid cancer	0.000653	0.000659	CcSEcCtD
Travoprost—Rash—Doxorubicin—thyroid cancer	0.000641	0.000648	CcSEcCtD
Travoprost—Dermatitis—Doxorubicin—thyroid cancer	0.00064	0.000647	CcSEcCtD
Travoprost—Headache—Doxorubicin—thyroid cancer	0.000637	0.000643	CcSEcCtD
Travoprost—Nausea—Doxorubicin—thyroid cancer	0.000604	0.00061	CcSEcCtD
